For a patient with intracranial hemorrhage who is NPO (nil per os), should the IV fluid be switched from plain 0.9% sodium chloride (normal saline) to a 5% dextrose‑containing solution (D5W)?

Do Not Switch to D5-Containing Solutions in NPO Intracranial Hemorrhage Patients

For patients with intracranial hemorrhage who are NPO, continue isotonic saline (0.9% NaCl) and avoid switching to dextrose-containing solutions like D5W, as hypotonic fluids worsen cerebral edema and neurological outcomes.

Rationale: Brain Injury Requires Isotonic Fluids

The brain's rigid skull cannot accommodate volume expansion from hypotonic solutions. While D5W appears isotonic in vitro (250 mOsm/L), it functions as free water in vivo because glucose is rapidly metabolized 1. This creates a hypotonic effect that drives water into brain cells, worsening cerebral edema and increasing intracranial pressure.

Evidence from Brain Injury Guidelines

The 2022 French critical care guidelines explicitly recommend isotonic crystalloids as first-line therapy for acute brain injury patients to reduce mortality and improve neurological outcomes 2. This recommendation applies directly to intracranial hemorrhage, where maintaining normal osmolality (288±5 mOsm/kg) is critical.

The 2013 AHA/ASA stroke guidelines emphasize that hypotonic solutions like D5W distribute into intracellular spaces and exacerbate ischemic brain edema, while isotonic solutions (0.9% saline) remain in extracellular spaces and are safer 3. Although this guideline addresses ischemic stroke, the pathophysiology of cerebral edema applies equally to hemorrhagic stroke.

Experimental Evidence Shows Harm

Multiple animal studies demonstrate that D5W and other hypotonic solutions worsen outcomes after brain injury:

• D5W significantly worsened brain edema (decreased specific gravity from 1.0395 to 1.0368) and increased mortality to 50% at 24 hours after closed head trauma, while 0.9% saline caused no significant edema worsening 4, 5
• 0.45% saline similarly worsened cerebral edema and increased mortality to 50%, while isotonic solutions did not 6
• A mere 3% decrease in plasma osmolality increases intracranial pressure by approximately 15 mmHg 7

Clinical Context: NPO Status Does Not Change Fluid Choice

The fact that a patient is NPO does not justify switching to dextrose-containing solutions. Here's why:

For glucose provision: If concerned about hypoglycemia or providing calories:

• Monitor blood glucose every 2-4 hours while NPO 8
• Treat hypoglycemia (<60 mg/dL) with 25 mL of 50% dextrose IV push, not maintenance D5W 3
• Consider enteral nutrition via nasogastric tube if prolonged NPO expected
• Peripheral or central parenteral nutrition if enteral route unavailable

For sodium concerns: The 2025 diabetes guidelines show that when glucose reaches target ranges during hyperglycemic crises, fluids should be changed to D5 with 0.45-0.75% NaCl 8. However, this applies to diabetic emergencies with specific metabolic derangements, not to intracranial hemorrhage patients who need consistent isotonic therapy.

Practical Management Algorithm

Maintain Isotonic Fluids

• Continue 0.9% NaCl at maintenance rates (approximately 30 mL/kg/day for euvolemic patients) 3
• Adjust rate based on volume status, not NPO status

Monitor Key Parameters

• Serum osmolality: Target 290-310 mOsm/kg; avoid decreases >3 mOsm/kg/hour 9, 10
• Serum sodium: Correct for hyperglycemia if present (add 1.6 mEq/L for each 100 mg/dL glucose >100 mg/dL) 9, 10
• Blood glucose: Check every 2-4 hours while NPO 8

Address Nutritional Needs Separately

• If NPO >24-48 hours, initiate enteral nutrition via feeding tube
• If enteral route contraindicated, use parenteral nutrition
• Never use D5W as maintenance fluid for "nutrition" in brain injury patients

Common Pitfalls to Avoid

1. Do not use D5W thinking it's "isotonic" - it acts as free water after glucose metabolism
2. Do not switch to hypotonic solutions (0.45% saline, D5W, Ringer's lactate [256 mOsm/kg]) in any brain injury patient 2
3. Do not confuse diabetic ketoacidosis protocols (which use D5-containing solutions once glucose normalizes) with brain injury management 9, 8, 9, 10, 9
4. Avoid arterial line flush contamination if using glucose-containing solutions elsewhere - even 0.03 mL contamination of a 1 mL sample causes dangerous glucose measurement errors 11

Special Considerations

If hypertonic therapy needed: For elevated intracranial pressure, use 23.4% or 3% hypertonic saline, not hypotonic solutions 12, 13. Recent evidence shows 23.4% NaCl can be safely administered peripherally with low extravasation rates (6.4%) 13.

Recent comparative data: A 2025 retrospective study in acute ischemic stroke patients treated with thrombolysis found that balanced solutions were associated with increased 90-day disability (OR 6.3) compared to normal saline, though this requires confirmation in larger trials 14. For intracranial hemorrhage specifically, normal saline remains the standard.